U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Substance Class Protein
Created
by admin
on Wed Apr 02 07:27:32 GMT 2025
Edited
by admin
on Wed Apr 02 07:27:32 GMT 2025
Protein Type BISPECIFIC ANTIBODY
Protein Sub Type IGG4
Sequence Origin HUMAN
Sequence Type COMPLETE
Record UNII
02Z59O1UOM
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
REGN-7075
Preferred Name English
Dalmitamig
INN   USAN  
Official Name English
dalmitamig [INN]
Common Name English
Immunoglobulin G4 [230-proline,235-proline,236-valine,237-alanine,de-238-glycine,436-arginine,437-phenylalanine,446-proline], anti-(human CD28 antigen) (human monoclonal REGN7075 ?4-chain), disulfide with human monoclonal REGN7075 ?-chain,(228?227'),(231
Common Name English
REGN 7075 [WHO-DD]
Common Name English
REGN7075
Code English
DALMITAMIG [USAN]
Common Name English
Code System Code Type Description
CAS
2765077-69-6
Created by admin on Wed Apr 02 07:27:32 GMT 2025 , Edited by admin on Wed Apr 02 07:27:32 GMT 2025
PRIMARY
INN
13010
Created by admin on Wed Apr 02 07:27:32 GMT 2025 , Edited by admin on Wed Apr 02 07:27:32 GMT 2025
PRIMARY
USAN
LM-18
Created by admin on Wed Apr 02 07:27:32 GMT 2025 , Edited by admin on Wed Apr 02 07:27:32 GMT 2025
PRIMARY
SMS_ID
300000025422
Created by admin on Wed Apr 02 07:27:32 GMT 2025 , Edited by admin on Wed Apr 02 07:27:32 GMT 2025
PRIMARY
NCI_THESAURUS
C178284
Created by admin on Wed Apr 02 07:27:32 GMT 2025 , Edited by admin on Wed Apr 02 07:27:32 GMT 2025
PRIMARY
FDA UNII
02Z59O1UOM
Created by admin on Wed Apr 02 07:27:32 GMT 2025 , Edited by admin on Wed Apr 02 07:27:32 GMT 2025
PRIMARY
From To
4_135 4_195
4_23 4_89
3_135 3_195
3_23 3_89
2_367 2_425
2_261 2_321
2_148 2_204
2_135 4_215
2_22 2_95
1_368 1_426
1_262 1_322
1_231 2_230
1_228 2_227
1_149 1_205
1_136 3_215
1_22 1_95
Glycosylation Type MAMMALIAN
Glycosylation Link Type Site
N 1_298
N 2_297
Related Record Type Details
ACTIVE MOIETY
Bridge EGFR positive tumor cells with CD28 positive T cells and provide amplified TCR-CD3 complex-mediated T cell activation within the tumor through the activation of CD28 signaling.
Name Property Type Amount Referenced Substance Defining Parameters References
Molecular Formula CHEMICAL
MOL_WEIGHT:NUMBER AVERAGE CHEMICAL